Article
Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2004
Murakami Takayoshi, Tokunaga Naoyuki, Waku Toshihiko, Gomi Shinya, Kagawa Shunsuke, Tanaka Noriaki, Fujiwara Toshiyoshi
Abstract excerpt
PURPOSE: Dendritic cells (DCs) are attractive effectors for cancer immunotherapy because of their potential to function as professional antigen-presenting cells for initiating cellular immune responses. The tumor suppressor gene p53 is pivotal in the regulation of apoptosis, and approximately 50% of human malignancies exhibit mutation and aberrant expression of p53. We investigated the antitumor effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
